Neurogene Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$31.27

-1.35 (-4.14%)

As of May 16, 2:02 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -19.6% upside

Low Target $17.03

Average Target $25.14

High Target $37.02

Current Price $31.27

Current
$31.27

Target
$25.14

$17.03 $25.14 avg $37.02

Scenario Analysis

Bear Case

$17.03

-45.5%

Low target

Base Case

$25.14

-19.6%

Avg target

Bull Case

$37.02

+18.4%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$37.27

-16.1% from high

52-Week Low

$14.65

+113.4% from low

Target vs 52W High

$25.14

-32.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%